Although the OR of PM subgroups in comparison to placebo were not statistically significant in relation to mortality, the intravenous and inhaled PMs group, including treprostinil and iloprost, showed a strong trend in reducing mortality.
← all excerpts
Adverse Events of Prostacyclin Mimetics in Pulmonary Arterial Hypertension: A Systematic Review and Meta-Analysis.
1
—
—